OncoVantaHealthPrecision Oncology
Therapy Matrix
Etcamah (camizestrant)Rx Only

Form

tablets

Strength

75 mg

Pack

30 tablets

Breast Cancer

Etcamah

camizestrant · 75 mg

Efficacy Gauge · Clinical Signal

Target Engagement92%
Progression-Free Survival78%
Tolerability Profile84%

Mechanism of Action

Camizestrant is a next-generation oral selective estrogen receptor degrader (SERD) that binds and degrades the estrogen receptor, eliminating estrogen-driven proliferative signaling in ER-positive breast tumors.

Manufacturer

AstraZeneca

Target Protein

ER

Delivery

Tablets

Quantity

30 tablets

Critical Safety Information

Etcamah is a prescription therapy. It may interact with CYP3A4 inhibitors and hormonal treatments. Do not co-administer with grapefruit. Report pregnancy or nursing status immediately. Requires ongoing hepatic monitoring.

Pricing Tier · Select Quantity

Total

$2,890

All orders require a valid prescription and clinical review before fulfillment. Final pricing confirmed after verification.

OncoVantaHealth

A clinical-grade command center for life-extending oncology therapies. Precision access, transparent pricing, and scientifically vetted care.

Rx Only · Prescription Therapies

Affiliated with Princess Margaret Cancer Centre · UHN

Support

This storefront provides access to prescription oncology therapies. All orders require a valid prescription and clinical review. Not a substitute for medical advice.